3B Blackbio Dx Limited
3BBLACKBIO (NSE) · 3BBLACKBIO (BSE 532067) · ISIN INE994E01018 · Healthcare Service Provider · Est. 1972 · listed 2026 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹319.02 cr | ₹0 cr | ₹350.37 cr |
| 30 Sep 2025 standalone | ₹297.1 cr | ₹0.26 cr | ₹313.51 cr |
| 31 Mar 2025 standalone | ₹272.79 cr | ₹0.31 cr | ₹297.12 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 40.95% | 2.46% | 2.33% | 59.05% |
Latest filings
- Scrutinizer''s Report and Voting report for 54th AGM 30 September 2026 · BSE
- Outcome of AGM 29 September 2026 · BSE
- Annual General Meeting to be held on 29th September, 2026 7 September 2026 · BSE
- Dividend updates 7 September 2026 · BSE
- Record date and date of book closure for the purpose of Dividend and AGM 7 September 2026 · BSE
Other companies in Healthcare Service Provider
- Dr. Lal Path Labs Ltd.
- Metropolis Healthcare Limited
- Thyrocare Technologies Limited
- Vijaya Diagnostic Centre Limited
- Krsnaa Diagnostics Limited
- One Global Service Provider Limited
- Nephrocare Health Services Limited
- Suraksha Diagnostic Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.